Skip to main content

Table 3 Patients who received or did not receive RLAT who had 24 months of data and received RLAT within 28 days of the study visit

From: Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results

Visit

Receiving RLAT

Not Receiving RLAT

Baseline

n

%

n

%

 

202

100

0

0

3 months

182

90.1

20

9.9

6 months

182

90.1

20

9.9

9 months

173

85.6

29

14.4

12 months

167

82.7

35

17.3

15 months

164

81.2

38

18.8

18 months

163

80.7

39

19.3

21 months

160

79.2

42

20.8

24 months

156

77.2

46

22.8